The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Therapeutic strategies to combat antibiotic resistance
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Brock Biology of Microorganisms
Madigan, M. T., Bender, K. S., Buckley, D. H., Sattley, W. M., & Stahl, D. A. (1996) · Cited by 5,759
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Antiseptics and Disinfectants: Activity, Action, and Resistance
McDonnell, G., & Russell, A. D. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.147 · Cited by 4,780
Antibiotic resistance of bacteria in biofilms
Stewart, P. S., & William Costerton, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05321-1 · Cited by 4,585
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Antibiotic resistance of bacterial biofilms
Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S., & Ciofu, O. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.011 · Cited by 3,225
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
Antibiotic resistance and its cost: is it possible to reverse resistance?
Andersson, D. I., & Hughes, D. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2319 · Cited by 2,294
Biomaterial-Centered Infection: Microbial Adhesion Versus Tissue Integration
Gristina, A. G. (1987) · Science · doi:10.1126/science.3629258 · Cited by 2,156
Molecular Mechanisms of Antibacterial Multidrug Resistance
Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647
Molecular mechanisms that confer antibacterial drug resistance
Walsh, C. (2000) · Nature · doi:10.1038/35021219 · Cited by 1,578
Azam, A., Ahmed, Oves, Khan, Habib, & Memic, A. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s35347 · Cited by 1,467
Aminoglycoside modifying enzymes
Ramirez, M. S., & Tolmasky, M. E. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.08.003 · Cited by 1,464
Nanotechnology as a therapeutic tool to combat microbial resistance
Pelgrift, R. Y., & Friedman, A. J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.011 · Cited by 1,432
Fayaz, A. M., Balaji, K., Girilal, M., Yadav, R., Kalaichelvan, P. T., & Venketesan, R. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.04.006 · Cited by 1,417
Resistance to Antibiotics: Are We in the Post-Antibiotic Era?
Alanis, A. J. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.06.009 · Cited by 1,417
Diekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362
Liposomes in drug delivery: Progress and limitations
Sharma, A. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00135-x · Cited by 1,253
The co-evolution of host cationic antimicrobial peptides and microbial resistance
Peschel, A., & Sahl, H.-G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1441 · Cited by 1,062
Ribosome-targeting antibiotics and mechanisms of bacterial resistance
Wilson, D. N. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3155 · Cited by 1,054
Sublethal Antibiotic Treatment Leads to Multidrug Resistance via Radical-Induced Mutagenesis
Kohanski, M. A., DePristo, M. A., & Collins, J. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.003 · Cited by 985
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
Efflux-Mediated Drug Resistance in Bacteria: An Update
Li, X.-Z., & Nikaido, H. (2009) · Drugs · doi:10.2165/11317030-000000000-00000 · Cited by 966
Antibacterial agents based on the cyclic d,l-α-peptide architecture
Fernandez-Lopez, S., Kim, H.-S., Choi, E. C., Delgado, M., Granja, J. R., Khasanov, A., Kraehenbuehl, K., Long, G., Weinberger, D. A., Wilcoxen, K. M., et al. (2001) · Nature · doi:10.1038/35086601 · Cited by 938
Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
Bacterial resistance to antibiotics: Enzymatic degradation and modification
WRIGHT, G. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.002 · Cited by 897
Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance
Fernández, L., & Hancock, R. E. W. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00043-12 · Cited by 892
Development of Nanoparticles for Antimicrobial Drug Delivery
Zhang, L., Pornpattananangkul, D., Hu, C.-M., & Huang, C.-M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416290 · Cited by 886
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05041-11 · Cited by 836
Exploiting Quorum Sensing To Confuse Bacterial Pathogens
LaSarre, B., & Federle, M. J. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00046-12 · Cited by 820
Evolutionary paths to antibiotic resistance under dynamically sustained drug selection
Toprak, E., Veres, A., Michel, J.-B., Chait, R., Hartl, D. L., & Kishony, R. (2012) · Nature Genetics · doi:10.1038/ng.1034 · Cited by 764
Combating Antimicrobial Resistance: Policy Recommendations to Save Lives
Infectious Diseases Society of America (IDSA) (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir153 · Cited by 733
Antimicrobial Polymers in Solution and on Surfaces: Overview and Functional Principles
Siedenbiedel, F., & Tiller, J. C. (2012) · Polymers · doi:10.3390/polym4010046 · Cited by 724
Roberts, R. R., Hota, B., Ahmad, I., Scott II, R. D., Foster, S. D., Abbasi, F., Schabowski, S., Kampe, L. M., Ciavarella, G. G., Supino, M., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/605630 · Cited by 705
Presenting Vancomycin on Nanoparticles to Enhance Antimicrobial Activities
Gu, H., Ho, P. L., Tong, E., Wang, L., & Xu, B. (2003) · Nano Letters · doi:10.1021/nl034396z · Cited by 703
Mutation Frequencies and Antibiotic Resistance
Martinez, J. L., & Baquero, F. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1771-1777.2000 · Cited by 694
Bacterial charity work leads to population-wide resistance
Lee, H. H., Molla, M. N., Cantor, C. R., & Collins, J. J. (2010) · Nature · doi:10.1038/nature09354 · Cited by 638
Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces
Costa, F., Carvalho, I. F., Montelaro, R. C., Gomes, P., & Martins, M. C. L. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.11.005 · Cited by 627
Combination approaches to combat multidrug-resistant bacteria
Worthington, R. J., & Melander, C. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.12.006 · Cited by 625
Antibiotic-eluting medical devices for various applications
ZILBERMAN, M., & ELSNER, J. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.020 · Cited by 610
The molecular evolution of methicillin-resistant Staphylococcus aureus
Deurenberg, R. H., Vink, C., Kalenic, S., Friedrich, A. W., Bruggeman, C. A., & Stobberingh, E. E. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01573.x · Cited by 597
Antimicrobial polymers: mechanism of action, factors of activity, and applications
Timofeeva, L., & Kleshcheva, N. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2920-9 · Cited by 579
Inhibition of Mutation and Combating the Evolution of Antibiotic Resistance
Cirz, R. T., Chin, J. K., Andes, D. R., de Crécy-Lagard, V., Craig, W. A., & Romesberg, F. E. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030176 · Cited by 576
In vitro assessments of nanomaterial toxicity
Jones, C. F., & Grainger, D. W. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.005 · Cited by 554
Tew, G. N., Scott, R. W., Klein, M. L., & DeGrado, W. F. (2010) · Accounts of Chemical Research · doi:10.1021/ar900036b · Cited by 552
Guilhelmelli, F., Vilela, N., Albuquerque, P., Derengowski, L. D. S., Silva-Pereira, I., & Kyaw, C. M. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00353 · Cited by 546
Cationic Antimicrobial Polymers and Their Assemblies
Carmona-Ribeiro, A., & De Melo Carrasco, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14059906 · Cited by 532
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
Ejim, L., Farha, M. A., Falconer, S. B., Wildenhain, J., Coombes, B. K., Tyers, M., Brown, E. D., & Wright, G. D. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.559 · Cited by 525
Conjugative plasmids: vessels of the communal gene pool
Norman, A., Hansen, L. H., & Sørensen, S. J. (2009) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2009.0037 · Cited by 524
Persister cells and the riddle of biofilm survival
Lewis, K. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0111-6 · Cited by 520
Population and evolutionary dynamics of phage therapy
Levin, B. R., & Bull, J. J. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro822 · Cited by 511
Gottenbos, B., van der Mei, H. C., Klatter, F., Nieuwenhuis, P., & Busscher, H. J. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00263-0 · Cited by 505
Antibacterial surfaces for biomedical devices
Vasilev, K., Cook, J., & Griesser, H. J. (2009) · Expert Review of Medical Devices · doi:10.1586/erd.09.36 · Cited by 504
An Alternative Bactericidal Mechanism of Action for Lantibiotic Peptides That Target Lipid II
Hasper, H. E., Kramer, N. E., Smith, J. L., Hillman, J. D., Zachariah, C., Kuipers, O. P., de Kruijff, B., & Breukink, E. (2006) · Science · doi:10.1126/science.1129818 · Cited by 501
Drug/device combinations for local drug therapies and infection prophylaxis
Wu, P., & Grainger, D. W. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.11.031 · Cited by 491
Phage-Antibiotic Synergy (PAS): β-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth
Comeau, A., Tétart, F., Trojet, S. N., Prère, M. F., & Krisch, H. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000799 · Cited by 488
Dybul, M., Fauci, A. S., Bartlett, J. G., Kaplan, J. E., & Pau, A. K. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_2-200209031-00001 · Cited by 482
Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages
Joerger, R. (2003) · Poultry Science · doi:10.1093/ps/82.4.640 · Cited by 465
Muller, G., & Kramer, A. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn125 · Cited by 449
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
Huttner, A., Harbarth, S., Carlet, J., Cosgrove, S., Goossens, H., Holmes, A., Jarlier, V., Voss, A., Pittet, D., & participants, F. T. W. H.-A. I. F. (2013) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-2-31 · Cited by 447
Stigter, M., Bezemer, J., de Groot, K., & Layrolle, P. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.06.011 · Cited by 446
De novo design of biomimetic antimicrobial polymers
Tew, G. N., Liu, D., Chen, B., Doerksen, R. J., Kaplan, J., Carroll, P. J., Klein, M. L., & DeGrado, W. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082046199 · Cited by 442
Antibiotics in the clinical pipeline in 2013
Butler, M. S., Blaskovich, M. A., & Cooper, M. A. (2013) · The Journal of Antibiotics · doi:10.1038/ja.2013.86 · Cited by 433
Novel Strategies for the Prevention and Treatment of Biofilm Related Infections
Chen, M., Yu, Q., & Sun, H. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140918488 · Cited by 429
Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications
Pinto-Alphandary, H., Andremont, A., & Couvreur, P. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00121-1 · Cited by 428
Allahverdiyev, A. M., Kon, K. V., Abamor, E. S., Bagirova, M., & Rafailovich, M. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.121 · Cited by 411
Harris, L. G., Tosatti, S., Wieland, M., Textor, M., & Richards, R. G. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.11.033 · Cited by 393
Campoccia, D., Montanaro, L., Speziale, P., & Arciola, C. R. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.005 · Cited by 392
Collagen as a carrier for on-site delivery of antibacterial drugs
Ruszczak, Z. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.08.007 · Cited by 367
Liposomes as delivery systems for antibiotics
Drulis-Kawa, Z., & Dorotkiewicz-Jach, A. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.11.033 · Cited by 356
Drug interactions and the evolution of antibiotic resistance
Yeh, P. J., Hegreness, M. J., Aiden, A. P., & Kishony, R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2133 · Cited by 350
Bacterial evolution of antibiotic hypersensitivity
Lázár, V., Pal Singh, G., Spohn, R., Nagy, I., Horváth, B., Hrtyan, M., Busa‐Fekete, R., Bogos, B., Méhi, O., Csörgő, B., et al. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.57 · Cited by 350
Freire-Moran, L., Aronsson, B., Manz, C., Gyssens, I. C., So, A. D., Monnet, D. L., & Cars, O. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.02.003 · Cited by 335
Local Antibiotic Therapy in the Treatment of Open Fractures and Osteomyelitis
Zalavras, C. G., Patzakis, M. J., & Holtom, P. (2004) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000143571.18892.8d · Cited by 327
Surface Engineering of Liposomes for Stealth Behavior
Nag, O., & Awasthi, V. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5040542 · Cited by 322
Basis for effective combination cancer chemotherapy with antimetabolites
Peters, G. J., van der Wilt, C. L., van Moorsel, C. J. A., Kroep, J. R., Bergman, A. M., & Ackland, S. P. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00086-3 · Cited by 301
Accelerated evolution of resistance in multidrug environments
Hegreness, M., Shoresh, N., Damian, D., Hartl, D., & Kishony, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805965105 · Cited by 300
Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery
Neut, D. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.6.885 · Cited by 296
Pornpattananangkul, D., Zhang, L., Olson, S., Aryal, S., Obonyo, M., Vecchio, K., Huang, C.-M., & Zhang, L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja111110e · Cited by 293
New β-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World
Drawz, S. M., Papp-Wallace, K. M., & Bonomo, R. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00826-13 · Cited by 286
Lohner, K., & Prenner, E. J. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00204-7 · Cited by 284
Reducing infections through nanotechnology and nanoparticles
Webster, T. J., & Taylor (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s22021 · Cited by 267
Infectious disease: Connecting innate immunity to biocidal polymers
Gabriel, G. J., Som, A., Madkour, A. E., Eren, T., & Tew, G. N. (2007) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2007.03.002 · Cited by 264
Moran, E., Masters, S., Berendt, A. R., McLardy-Smith, P., Byren, I., & Atkins, B. L. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.01.007 · Cited by 260
Combination therapies for combating antimicrobial resistance
Fischbach, M. A. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.08.003 · Cited by 259
Antibiotic adjuvants: multicomponent anti-infective strategies
Kalan, L., & Wright, G. D. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001766 · Cited by 249
Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases
Andrade, F., Rafael, D., Videira, M., Ferreira, D., Sosnik, A., & Sarmento, B. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.020 · Cited by 245
Howlin, R. P., Brayford, M. J., Webb, J. S., Cooper, J. J., Aiken, S. S., & Stoodley, P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03676-14 · Cited by 245
Controlled release of antibiotics from coated orthopedic implants
Price, J. S., Tencer, A. F., Arm, D. M., & Bohach, G. A. (1996) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199603)30:3<281::aid-jbm2>3.0.co;2-m · Cited by 243
Markoishvili, K., Tsitlanadze, G., Katsarava, R., Glenn, J., Morris Jr., M. D., & Sulakvelidze, A. (2002) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2002.01451.x · Cited by 243
Contribution of phenotypic heterogeneity to adaptive antibiotic resistance
Sánchez-Romero, M. A., & Casadesús, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316084111 · Cited by 242
On the Enhanced Antibacterial Activity of Antibiotics Mixed with Gold Nanoparticles
Burygin, G., Khlebtsov, B., Shantrokha, A., Dykman, L., Bogatyrev, V., & Khlebtsov, N. (2009) · Nanoscale Research Letters · doi:10.1007/s11671-009-9316-8 · Cited by 239
Ciprofloxacin-Protected Gold Nanoparticles
Tom, R. T., Suryanarayanan, V., Reddy, P. G., Baskaran, S., & Pradeep, T. (2004) · Langmuir · doi:10.1021/la0358567 · Cited by 231
Nonoptimal microbial response to antibiotics underlies suppressive drug interactions
Bollenbach, T., Quan, S., Chait, R., & Kishony, R. (2009) · Cell · doi:10.1016/j.cell.2009.10.025 · Cited by 227
Antibiotics and antibiotic resistance: A bitter fight against evolution
Rodríguez-Rojas, A., Rodríguez-Beltrán, J., Couce, A., & Blázquez, J. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.02.004 · Cited by 223
Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens
Burrowes, B., Harper, D. R., Anderson, J., McConville, M., & Enright, M. C. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.90 · Cited by 218
K. Bhardwaj, A., Vinothkumar, K., & Rajpara, N. (2013) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489113805290809 · Cited by 210
Pena-Miller, R., Laehnemann, D., Jansen, G., Fuentes-Hernandez, A., Rosenstiel, P., Schulenburg, H., & Beardmore, R. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001540 · Cited by 209
Persisters and beyond: Mechanisms of phenotypic drug resistance and drug tolerance in bacteria
Kester, J. C., & Fortune, S. M. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.869543 · Cited by 202
Antimicrobial polymers as synthetic mimics of host‐defense peptides
Kuroda, K., & Caputo, G. A. (2013) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1199 · Cited by 197
Antibiotic‐Releasing Silk Biomaterials for Infection Prevention and Treatment
Pritchard, E. M., Valentin, T., Panilaitis, B., Omenetto, F., & Kaplan, D. L. (2013) · Advanced Functional Materials · doi:10.1002/adfm.201201636 · Cited by 191
Alves, D., & Olívia Pereira, M. (2014) · Biofouling · doi:10.1080/08927014.2014.889120 · Cited by 189
Christensen, L. D., van Gennip, M., Jakobsen, T. H., Alhede, M., Hougen, H. P., Hoiby, N., Bjarnsholt, T., & Givskov, M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks002 · Cited by 177
Balaban, N., Giacometti, A., Cirioni, O., Gov, Y., Ghiselli, R., Mocchegiani, F., Viticchi, C., Del Prete, M. S., Saba, V., Scalise, G., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/345879 · Cited by 173
Outwitting Evolution: Fighting Drug-Resistant TB, Malaria, and HIV
Goldberg, D. E., Siliciano, R. F., & Jacobs, W. R. (2012) · Cell · doi:10.1016/j.cell.2012.02.021 · Cited by 168
Tunable Antibacterial Coatings That Support Mammalian Cell Growth
Vasilev, K., Sah, V., Anselme, K., Ndi, C., Mateescu, M., Dollmann, B., Martinek, P., Ys, H., Ploux, L., & Griesser, H. J. (2010) · Nano Letters · doi:10.1021/nl903274q · Cited by 167
Antimicrobial peptides from animals: focus on invertebrates
Vizioli, J., & Salzet, M. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02105-3 · Cited by 165
Bell, J. M., & Turnidge, J. D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.880-882.2002 · Cited by 165
Fast Disinfecting Antimicrobial Surfaces
Madkour, A. E., Dabkowski, J. M., Nüsslein, K. R., & Tew, G. N. (2008) · Langmuir · doi:10.1021/la802953v · Cited by 165
A Biosurfactant-Sophorolipid Acts in Synergy with Antibiotics to Enhance Their Efficiency
Navare, K. J., & Prabhune, A. A. (2013) · BioMed Research International · doi:10.1155/2013/512495 · Cited by 162
Kourtesi, C., Ball, A. R., Huang, Y.-Y., Jachak, S. M., Vera, D. M. A., Khondkar, P., Gibbons, S., Hamblin, M. R., & Tegos, G. P. (2013) · The Open Microbiology Journal · doi:10.2174/1874285801307010034 · Cited by 159
Biotechnological exploitation of bacteriophage research
Petty, N. K., Evans, T. J., Fineran, P. C., & Salmond, G. P. C. (2006) · Trends in biotechnology · doi:10.1016/j.tibtech.2006.11.003 · Cited by 156
The need for new therapeutic agents: what is in the pipeline?
SHAH, P. M. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01141.x · Cited by 147
Seil, J. T., & Webster, T. J. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.03.018 · Cited by 144
New treatment options against gram-negative organisms
Bassetti, M., Ginocchio, F., & Mikulska, M. (2011) · Critical Care · doi:10.1186/cc9997 · Cited by 139
Development of Quorum-Based Anti-Virulence Therapeutics Targeting Gram-Negative Bacterial Pathogens
Tay, S. B., & Yew, W. S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140816570 · Cited by 138
Mechanism-independent method for predicting response to multidrug combinations in bacteria
Wood, K. B., Nishida, S., Sontag, E. D., & Cluzel, P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201281109 · Cited by 132
Control of Nosocomial Antimicrobial-Resistant Bacteria: A Strategic Priority for Hospitals Worldwide
Goldmann, D. A., & Huskins, W. C. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s139 · Cited by 130
Wagner, V., Koberstein, J. T., & Bryers, J. D. (2003) · Biomaterials · doi:10.1016/j.biomaterials.2003.09.020 · Cited by 124
Sampath, L. A., Tambe, S. M., & Modak, S. M. (2001) · Infection Control and Hospital Epidemiology · doi:10.1086/501836 · Cited by 122
Gerdt, J. P., & Blackwell, H. E. (2014) · ACS Chemical Biology · doi:10.1021/cb5004288 · Cited by 121
Proteome studies of bacterial antibiotic resistance mechanisms
Vranakis, I., Goniotakis, I., Psaroulaki, A., Sandalakis, V., Tselentis, Y., Gevaert, K., & Tsiotis, G. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.10.027 · Cited by 111
Antimicrobial activity of an abiotic host defense peptide mimic
Tew, G. N., Clements, D. J., Tang, H., Arnt, L., & Scott, R. W. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.001 · Cited by 109
Hirakawa, H., & Tomita, H. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00114 · Cited by 109
Chitosan Sponges to Locally Deliver Amikacin and Vancomycin: A Pilot In Vitro Evaluation
Noel, S. P., Courtney, H. S., Bumgardner, J. D., & Haggard, W. O. (2010) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-010-1324-6 · Cited by 104
Polyurethane coatings release bioactive antibodies to reduce bacterial adhesion
Rojas, I. A., Slunt, J. B., & Grainger, D. W. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00195-9 · Cited by 104
In silico tools for the analysis of antibiotic biosynthetic pathways
Weber, T. (2014) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2014.02.001 · Cited by 104
Infection Control in the Multidrug-Resistant Era: Tending the Human Microbiome
Tosh, P. K., & McDonald, L. C. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir899 · Cited by 101
Fritz, J. H., Brunner, S., Birnstiel, M. L., Buschle, M., von Gabain, A., Mattner, F., & Zauner, W. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.03.007 · Cited by 99
Novel approaches for the design and discovery of quorum-sensing inhibitors
Scutera, S., Zucca, M., & Savoia, D. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.894974 · Cited by 94
Dizman, B., Elasri, M. O., & Mathias, L. J. (2004) · Biomacromolecules · doi:10.1021/bm049383+ · Cited by 92
Liposomal antibiotics for the treatment of infectious diseases
Alhariri, M., Azghani, A. O., & Omri, A. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.822860 · Cited by 86
Appropriate antimicrobial prescribing: approaches that limit antibiotic resistance.
Colgan, R., & Powers, J. H. (2001) · PubMed · Cited by 84
Inhibition of Bacterial Multidrug Resistance by Celecoxib, a Cyclooxygenase-2 Inhibitor
Kalle, A. M., & Rizvi, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00735-10 · Cited by 83
Hu, Y., Shamaei‐Tousi, A., Liu, Y., & Coates, A. R. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011818 · Cited by 80
PERSPECTIVE: Evolutionary biology and the avoidance of antimicrobial resistance
Read, A. F., & Huijben, S. (2009) · Evolutionary Applications · doi:10.1111/j.1752-4571.2008.00066.x · Cited by 77
Block copolymer mixtures as antimicrobial hydrogels for biofilm eradication
Lee, A. L. Z., Ng, V. W. L., Wang, W., Hedrick, J. L., & Yang, Y. Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.029 · Cited by 76
Synergy between Novel Antimicrobials and Conventional Antibiotics or Bacteriocins
Wolska, K. I., Grzes, K. M., & Kurek, A. (2012) · Polish Journal of Microbiology · doi:10.33073/pjm-2012-012 · Cited by 72
Kopeček, J. (1977) · PubMed · Cited by 72
Lawson, M. C., Shoemaker, R. L., Hoth, K. B., Bowman, C. N., & Anseth, K. S. (2009) · Biomacromolecules · doi:10.1021/bm900410a · Cited by 70
Auxiliary factors: a chink in the armor of MRSA resistance to β-lactam antibiotics
Roemer, T., Schneider, T., & Pinho, M. G. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.012 · Cited by 69
Responsive and “smart” antibacterial surfaces: Common approaches and new developments (Review)
Cavallaro, A., Taheri, S., & Vasilev, K. A. (2014) · Biointerphases · doi:10.1116/1.4866697 · Cited by 67
Bacteriophage therapy: an alternative to conventional antibiotics.
Mathur, M., Vidhani, S., & Mehndiratta, P. L. (2003) · PubMed · Cited by 64
Cirioni, O., Mocchegiani, F., Cacciatore, I., Vecchiet, J., Silvestri, C., Baldassarre, L., Ucciferri, C., Orsetti, E., Castelli, P., Provinciali, M., et al. (2012) · Peptides · doi:10.1016/j.peptides.2012.12.002 · Cited by 60
Combinatorial discovery process yields antimicrobial peptoids
Ng, S., Goodson, B., Ehrhardt, A. F., Moos, W. H., Siani, M., & Winter, J. A. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00132-7 · Cited by 59
Synthetic Mimics of Antimicrobial Peptides from Triaryl Scaffolds
Thaker, H. D., Sgolastra, F., Clements, D. J., Scott, R. W., & Tew, G. N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101410t · Cited by 50
Bactericidal Effect Obtained by Addition of Antibiotics to Dental Cements and Direct Filling Resins
Colton, M. B., & Ehrlich, E. (1953) · The Journal of the American Dental Association · doi:10.14219/jada.archive.1953.0206 · Cited by 47
Mavros, M. N., Mitsikostas, P. K., Alexiou, V. G., Peppas, G., & Falagas, M. E. (2012) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.06.040 · Cited by 47
Zilberman, M., Kraitzer, A., Grinberg, O., & Elsner, J. J. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00477-3_11 · Cited by 47
Biological performance of a novel synthetic furanone-based antimicrobial
Baveja, J. K., Li, G., Nordon, R. E., Hume, E. B. H., Kumar, N., Willcox, M. D. P., & Poole-Warren, L. A. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.02.007 · Cited by 44
Tan, H. L., Lin, W. T., & Tang, T. (2012) · The International Journal of Artificial Organs · doi:10.5301/ijao.5000163 · Cited by 43
Pajtasz‐Piasecka, E., Rossowska, J., Duś, D., Weber‐Dąbrowska, B., Zabłocka, A., & Górski, A. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.11.004 · Cited by 43
Tobramycin liposomes. Single subconjunctival therapy of pseudomonal keratitis.
Assil, K. K., Frucht-Perry, J., Ziegler, E. E., Schanzlin, D. J., Schneiderman, T. E., & Weinreb, R. N. (1991) · PubMed · Cited by 38
Tofuku, K., Koga, H., Yanase, M., & Komiya, S. (2012) · European Spine Journal · doi:10.1007/s00586-012-2435-4 · Cited by 34
Ahola, N., Männistö, N., Veiranto, M., Karp, M. T., Rich, J., Efimov, A., Seppälä, J. V., & Kellomäki, M. (2012) · Biomatter · doi:10.4161/biom.23162 · Cited by 33
Irwin, N., McCoy, C. P., Jones, D. S., & Gorman, S. P. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0927-x · Cited by 29
The optimal deployment of synergistic antibiotics: a control-theoretic approach
Peña‐Miller, R., Laehnemann, D., Schulenburg, H., Ackermann, M., & Beardmore, R. (2012) · Journal of The Royal Society Interface · doi:10.1098/rsif.2012.0279 · Cited by 25
Barekzi, N. A., Felts, A. G., Poelstra, K. A., Slunt, J. B., & Grainger, D. W. (2002) · Pharmaceutical Research · doi:10.1023/a:1021481122011 · Cited by 25
Structural effects on persister control by brominated furanones
Pan, J., & Ren, D. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.10.070 · Cited by 24
Ozaki, S., Saito, A., Nakaminami, H., Ōno, M., Noguchi, N., & Motomura, N. (2013) · Journal of Artificial Organs · doi:10.1007/s10047-013-0746-9 · Cited by 22
Micelle-based Systems for Pulmonary Drug Delivery and Targeting
Andrade, F., Videira, M., Ferreira, D., & Sarmento, B. F. C. C. (2011) · Drug Delivery Letters · doi:10.2174/2210303111101020171 · Cited by 22
Polymer-controlled release of tobramycin from bone graft void filler
Brooks, A. E., Brooks, B. D., Davidoff, S. N., Hogrebe, P. C., Fisher, M. A., & Grainger, D. W. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0155-x · Cited by 15
Self-citation
Cited by
The antimicrobial activity of nanoparticles: present situation and prospects for the future
Wang, L., Hu, C., & Shao, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s121956 · Cited by 4,062
Antibiotic resistance: a rundown of a global crisis
Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., Nisar, M. A., Alvi, R. F., Aslam, M. A., Qamar, M. U., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173867 · Cited by 2,552
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects
Uddin, T. M., Chakraborty, A. J., Khusro, A., Zidan, B. R. M., Mitra, S., Emran, T. B., Dhama, K., Ripon, M. K. H., Gajdács, M., Sahibzada, M. U. K., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.10.020 · Cited by 1,311
Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2
Caesar, L. K., & Cech, N. B. (2019) · Natural Product Reports · doi:10.1039/c9np00011a · Cited by 881
Imran, M., Das, K. R., & Naik, M. M. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2018.10.114 · Cited by 597
Metadata
- Authors
- Brooks, B. D., & Brooks, A. E.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 78
- Pages
- 14-27
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2010428513
- Cited by
- 367
- References
- 166
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.